PIEZO1 and Bartsocas-Papas syndrome 1: The current study highlights PIEZO1 as a potential target for treatment for numerous bladder pathologies, like IC/BPS, and offers a basic mechanistic understanding of how MSCs contribute to bladder function and dysfunction.